VTI (Vertebral Technologies, Inc.) is revolutionizing spinal fusion surgery with patented lateral expansion technology, allowing customization of each device to fit the unique shape of each patient’s vertebrae. Founded in 2005, VTI has leveraged its modular-assembly technology to deliver optimized solutions for both surgeons and patients. With over 7,000 InterFuse modular interbody fusion devices sold globally, VTI is making a significant impact in the Health Care and Information Technology industries. The company received a $2.50M Series B investment on 18 November 2015, signaling confidence in its innovative approach to spinal surgery. VTI's disruptive technology and market traction position it as an attractive opportunity for venture capital investment. For more information, visit VTI's website.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | $2.50M | - | 18 Nov 2015 | |
Venture Round | $2.51M | - | 22 Dec 2011 | |
Venture Round | $2.51M | - | 12 Oct 2010 | |
Series A | $1.07M | - | 15 Sep 2006 |
No recent news or press coverage available for VTI (Vertebral Technologies, Inc.).